Relationships of generalized and regional adiposity to insulin sensitivity in men.
Open accessAbstract
The relative impacts of regional and generalized adiposity on insulin sensitivity have not been fully defined. Therefore, we investigated the relationship of insulin sensitivity (measured using hyperinsulinemic, euglycemic clamp technique with [3-3H]glucose turnover) to total body adiposity (determined by hydrodensitometry) and regional adiposity. The latter was assessed by determining subcutaneous abdominal, intraperitoneal, and retroperitoneal fat masses (using magnetic resonance imaging) and the sum of truncal and peripheral skinfold thicknesses. 39 healthy middle-aged men with a wide range of adiposity were studied. Overall, the intraperitoneal and retroperitoneal fat constituted only 11 and 7% of the total body fat. Glucose disposal rate (Rd) and residual hepatic glucose output (rHGO) values during the 40 mU/m2.min insulin infusion correlated significantly with total body fat (r = -0.61 and 0.50, respectively), subcutaneous abdominal fat (r = -0.62 and 0.50, respectively), sum of truncal skinfold thickness (r = -0.72 and 0.57, respectively), and intraperitoneal fat (r = -0.51 and 0.44, respectively) but not to retroperitoneal fat. After adjusting for total body fat, the Rd and rHGO values showed the highest correlation with the sum of truncal skinfold thickness (partial r = -0.40 and 0.33, respectively). We conclude that subcutaneous truncal fat plays a major role in obesity-related insulin resistance in men, whereas intraperitoneal fat and retroperitoneal fat have a lesser role.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Both abdominal subcutaneous fat mass and visceral fat mass are associated with insulin resistance.
“Although both the abdominal subcutaneous fat mass and the visceral fat mass are associated with insulin resistance, 2”
From Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease (2004) · cites this paper as [2]
Abdominal obesity develops later in the course of the metabolic syndrome along with NAFLD and is likely more a consequence of insulin resistance in skeletal muscle rather than a primary cause of insulin resistance and atherogenic dyslipidemia.
“These data suggest that abdominal obesity develops later in the course of the metabolic syndrome along with NAFLD and that it is likely more a consequence of insulin resistance in skeletal muscle rather than a primary cause of insulin resistance and atherogenic dyslipidemia (5–7).”
From The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome (2007) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 71 · Cited by 759
- Authors
- Abate, N., Garg, A., Peshock, R. M., Stray-Gundersen, J., & Grundy, S. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1995-07-01
- Volume
- 96
- Issue
- 1
- Pages
- 88-98
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC185176
- OpenAlex
- W2153962063
- Semantic Scholar
- 5c07f452cf23e5621afaeb6b3e4aec90706183ea
- Cited by
- 759
- References
- 71
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 10 · 2023: 12 · 2022: 13 · 2021: 18 · 2020: 19 · 2019: 15 · 2018: 18 · 2017: 16 · 2016: 19 · 2015: 37 · 2014: 32 · 2013: 30 · 2012: 24
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health (5p01dk042582-04, HL-29252)
- National Heart, Lung, and Blood Institute (HL-292-52)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-42582, DK 02700)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- insulin sensitivity, insulin resistance, regional adiposity, total body fat, subcutaneous abdominal fat, intraperitoneal fat, retroperitoneal fat, hepatic glucose production, glucose disposal rate, obesity, middle-aged men
- MeSH terms
- Adipose Tissue, Adult, Fatty Acids, Nonesterified, Glucose, Humans, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review